科金生物

Biotech/Healthcare

Kejin Biotech is a developer and manufacturer of novel therapies for rare diseases and cancer. The company focuses on treating rare diseases with gene-editing technology and cell therapies, as well as developing and manufacturing novel anti-cancer drugs.

Latest round: Angel (2022)